UNKNOWN

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a literature report with the FDA on 2020-01-02 for UNKNOWN manufactured by William A. Cook Australia, Pty Ltd.

Event Text Entries

[173459376] A (b)(6)-year-old woman presented to the er 4 h after transvaginal oocyte retrieval (tvor) with acute hematuria and worsening suprapubic pain. She had ovulatory infertility due to polycystic ovarian syndrome. Immediately after discharge, the patient reported diffuse lower abdominal pain, particularly over suprapubic region, and difficulty in voiding. Her vital sign was stable. The physical examination revealed localized tenderness over lower abdomen without rebound pain and a dribbling urinary stream was observed during micturition. A transvaginal ultrasound showed a solid mass in the bladder (78 x 46 mm), 2 enlarged ovaries (68 x 50 mm and 71 x 61 mm), no pelvic fluid, and a normal-appearing uterus. Due to her symptoms of urinary retention, her bladder was drained using a plastic catheter, and hematuria was evident. A urinalysis indicated more than 500 red blood cells per high-power field. Laboratory analysis indicated leukocytosis (white blood cell count: 16,200/ml), but her hemoglobin and hematocrit were normal. She was managed conservatively with an indwelling three-way foley catheter for irrigation, and to draw away clots that obstructive in the bladder. A prophylactic antibiotic was also given. However, the bladder hematuria persisted, and sometimes even clogged the catheter. 5 days after admission, the laboratory examination showed decreased hemoglobin (from 12. 0 g/dl to 10. 8 g/dl). Transvaginal ultrasound revealed the bladder hematoma was still present compared with the examination previously performed (60 x 26 mm) due to the failure of continuous irrigation and further anemia, the cystoscopy was performed by the urogynecologist with the team to remove the clots and search for the potential bleeding site. The cystoscopy revealed dense blood clots and focal erythemous area on the mucosa of right lateral floor. No active bleeding or disrupted mucosa was found. Clot evacuation was performed using a cystoscope sheath with an ellik evacuator, followed by single-blastocyst transfer on the same day. She reported being comfortable, and had no further hematuria after this procedure. She was discharged 3 days after the cystoscopy, and transferred to a continuous progesterone and estradiol supplement.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number9680654-2020-00001
MDR Report Key9540871
Report SourceLITERATURE
Date Received2020-01-02
Date of Report2020-02-18
Date of Event2019-12-02
Date Mfgr Received2019-12-04
Date Added to Maude2020-01-02
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR NICOLAS BIDAUD
Manufacturer Street95 BRANDL STREET EIGHT MILE PLAINS
Manufacturer CityBRISBANE QLD 4113
Manufacturer CountryAS
Manufacturer PostalQLD 4113
Manufacturer Phone738411188
Manufacturer G1WILLIAM A. COOK AUSTRALIA, PTY LTD
Manufacturer Street95 BRANDL STREET EIGHT MILE PLAINS
Manufacturer CityBRISBANE QLD 4113
Manufacturer CountryAS
Manufacturer Postal CodeQLD 4113
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameUNKNOWN
Generic NameMQE NEEDLE, ASSISTED REPRODUCTION - OVUM PICK-UP ASPIRATION NEEDLES
Product CodeMQE
Date Received2020-01-02
Catalog NumberUNKNOWN
Lot NumberUNKNOWN
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerWILLIAM A. COOK AUSTRALIA, PTY LTD
Manufacturer Address95 BRANDL STREET EIGHT MILE PLAINS BRISBANE QLD 4113 AS QLD 4113


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-01-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.